158 related articles for article (PubMed ID: 38091158)
21. Advanced nodal stage predicts venous thromboembolism in patients with locally advanced non-small cell lung cancer.
Li R; Hermann G; Baldini E; Chen A; Jackman D; Kozono D; Nguyen P; Nohria A; Powell G; Mak R
Lung Cancer; 2016 Jun; 96():41-7. PubMed ID: 27133748
[TBL] [Abstract][Full Text] [Related]
22. Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients.
Yoon JH; Kim JW; Jeon YW; Lee SE; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Park CW; Cho SG
Korean J Intern Med; 2015 May; 30(3):362-71. PubMed ID: 25995667
[TBL] [Abstract][Full Text] [Related]
23. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
[TBL] [Abstract][Full Text] [Related]
24. Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality.
Ay C; Posch F; Kaider A; Zielinski C; Pabinger I
J Thromb Haemost; 2015 Mar; 13(3):390-7. PubMed ID: 25529107
[TBL] [Abstract][Full Text] [Related]
25. A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality.
Kuderer NM; Culakova E; Lyman GH; Francis C; Falanga A; Khorana AA
Oncologist; 2016 Jul; 21(7):861-7. PubMed ID: 27125754
[TBL] [Abstract][Full Text] [Related]
26. Nomogram based on the systemic immune-inflammation index for predicting the prognosis of diffuse large B-cell lymphoma.
Wu J; Zhu H; Zhang Q; Sun Y; He X; Liao J; Liu Y; Huang L
Asia Pac J Clin Oncol; 2023 Apr; 19(2):e138-e148. PubMed ID: 35754170
[TBL] [Abstract][Full Text] [Related]
27. Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: results from a prospective cohort study with Asian population.
Park LC; Woo SY; Kim S; Jeon H; Ko YH; Kim SJ; Kim WS
Thromb Res; 2012 Sep; 130(3):e6-12. PubMed ID: 22507288
[TBL] [Abstract][Full Text] [Related]
28. Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea.
Kim TM; Kim JS; Han SW; Hong YS; Kim I; Ha J; Kim SJ; Chung JW; Park JH; Lee D; Park S; Kim BK; Kim NK; Yoon SS
Thromb Res; 2009; 123(3):436-43. PubMed ID: 18579181
[TBL] [Abstract][Full Text] [Related]
29. [Mutational Spectrum and Prognosis Analysis of Young Patients with Diffuse Large B-Cell Lymphoma Based on Next-Generation Sequencing].
Lyu LY; Nie YL; Renaguli A; Qi XL; Muhebaier A; Zhai SS; An L; Mao M; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):403-410. PubMed ID: 37096512
[TBL] [Abstract][Full Text] [Related]
30. Increasing Incidence and Recurrence Rate of Venous Thromboembolism in Paediatric Oncology Patients in One Single Centre Over 25 Years.
Klaassen ILM; van Els AL; van de Wetering MD; van Ommen CH
Thromb Haemost; 2017 Nov; 117(11):2156-2162. PubMed ID: 28981557
[TBL] [Abstract][Full Text] [Related]
31. Venous thromboembolism following L-asparaginase treatment for lymphoid malignancies in Korea.
Lee JH; Lee J; Yhim HY; Oh D; Bang SM
J Thromb Haemost; 2017 Apr; 15(4):655-661. PubMed ID: 28150907
[TBL] [Abstract][Full Text] [Related]
32. The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis.
Zhang C; Zhang Z; Mi J; Wang X; Zou Y; Chen X; Nie Z; Luo X; Gan R
Medicine (Baltimore); 2019 Jun; 98(23):e15833. PubMed ID: 31169685
[TBL] [Abstract][Full Text] [Related]
33. The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer.
Lee KW; Bang SM; Kim S; Lee HJ; Shin DY; Koh Y; Lee YG; Cha Y; Kim YJ; Kim JH; Park DJ; Kim HH; Oh D; Lee JS
J Thromb Haemost; 2010 Mar; 8(3):540-7. PubMed ID: 20040044
[TBL] [Abstract][Full Text] [Related]
34. Cumulative incidence, risk factors and prognostic impact of venous thromboembolism in Japanese patients with advanced gastric cancer.
Arai H; Hironaka S; Minashi K; Denda T; Shimokawa M; Yamaguchi T
Jpn J Clin Oncol; 2017 Oct; 47(10):942-948. PubMed ID: 28981740
[TBL] [Abstract][Full Text] [Related]
35. Time to Event Analysis for the Development of Venous Thromboembolism After Spinal Fusion ≥ 5 Levels.
McClendon J; Smith TR; O'Shaughnessy BA; Sugrue PA; Thompson SE; Koski TR
World Neurosurg; 2015 Sep; 84(3):826-33. PubMed ID: 25871780
[TBL] [Abstract][Full Text] [Related]
36. Venous thromboembolic events in T-cell lymphoma patients: Incidence, risk factors and clinical features.
Lan Y; Guan J; Zhu J; Wang J; Li M; Sun C; Sun F; Huang J; Lu S; Zhang Y
Leuk Res; 2021 Apr; 103():106537. PubMed ID: 33631621
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.
Cohen AT; Katholing A; Rietbrock S; Bamber L; Martinez C
Thromb Haemost; 2017 Jan; 117(1):57-65. PubMed ID: 27709226
[TBL] [Abstract][Full Text] [Related]
38. Unprovoked venous thromboembolism and subsequent cancer risk: a population-based cohort study.
Sun LM; Chung WS; Lin CL; Liang JA; Kao CH
J Thromb Haemost; 2016 Mar; 14(3):495-503. PubMed ID: 26748492
[TBL] [Abstract][Full Text] [Related]
39. Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease.
Naik RP; Streiff MB; Haywood C; Segal JB; Lanzkron S
J Thromb Haemost; 2014 Dec; 12(12):2010-6. PubMed ID: 25280124
[TBL] [Abstract][Full Text] [Related]
40. Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS).
Posch F; Thaler J; Zlabinger GJ; Königsbrügge O; Koder S; Zielinski C; Pabinger I; Ay C
Clin Cancer Res; 2016 Jan; 22(1):200-6. PubMed ID: 26302981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
